Navigating the future of medical AI
Listen now
Description
While generative AI has dominated the spotlight in the past year, machine learning programs have already been significantly impacting patients and physicians for several years. The question now arises: how will the emergence of programs like ChatGPT, coupled with increasing calls to scrutinize their safety, influence the adoption of new AI programs and diagnostics in healthcare?   This week on “The Top Line,” Fierce’s Conor Hale interviews Peter Shen, the North American head of digital health at Siemens Healthineers, to explore what developers and regulators can do to ensure transparency in medical AI. He also dives into how the field could potentially benefit from a 21st-century update to the Hippocratic Oath.  To learn more about the topics in this episode:  2024 forecast: Will generative AI find what it needs to deliver for patients?  FDA to form advisory committee for digital health and AI  US government to launch AI Safety Institute, develop standards for biotech R&D  Biden to sign sweeping executive order pursuing 'safe, secure and trustworthy' AI development    See omnystudio.com/listener for privacy information.
More Episodes
The Fierce Biotech team published a four-part series this week exploring cell therapy, a modality that has faced clinical challenges, manufacturing constraints and multiple practice-changing events.   In today’s episode, Fierce’s Annalee Armstrong and Gabrielle Masson discuss the series of...
Published 05/31/24
Published 05/31/24
This week’s episode of “The Top Line,” is the final part of a three-part series diving into the latest advancements in cell and gene therapy manufacturing.  In this episode, Fierce Pharma’s Fraiser Kansteiner is joined by Bruce Levine, Ph.D., who is the co-inventor of Kymriah and the Barbara and...
Published 05/24/24